25
Participants
Start Date
April 30, 2009
Primary Completion Date
August 31, 2012
Study Completion Date
October 31, 2012
Lenalidomide
"Lenalidomide is a a derivative of thalidomide.~Orally-administered lenalidomide 10 mg will be taken daily on days 1 to 21 of 28-day cycle."
Melphalan
"Melphalan is a phenylalanine derivative of mechlorethamine.~Orally-administered melphalan 0.18 mg/kg will be taken on days 1 to 4 of a 28-day cycle"
Dexamethasone
"Dexamethasone is an anti-inflammatory and immunosuppressant steroid medication.~Orally-administered dexamethasone 40 mg orally once weekly of a 28-day cycle"
Stanford University Cancer Institute, Stanford
Collaborators (1)
Celgene Corporation
INDUSTRY
Stanford University
OTHER